Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garidel

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Biophysical Journal|April 27, 2019
Structure of a Therapeutic Full-Length Anti-NPRA IgG4 Antibody: Dissecting Conformational DiversityMichaela Blech, Stefan Hörer, Alexander B Kuhn, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspectsTobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Innate Immunity|April 5, 2008
Structural investigations into the interaction of hemoglobin and part structures with bacterial endotoxinsJörg Howe, Patrick Garidel, Manfred Roessle, et al.
The Journal of Biological Chemistry|February 9, 2008
Single particle characterization of iron-induced pore-forming alpha-synuclein oligomersMarcus Kostka, Tobias Högen, Karin M Danzer, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyaminesGuillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Journal of Molecular Biology|March 22, 2017
Prediction and Reduction of the Aggregation of Monoclonal AntibodiesRob van der Kant, Anne R Karow-Zwick, Joost Van Durme, et al.
Journal of Pharmaceutical Sciences|January 19, 2026
Do we worry too much about polysorbate degradation? An industry-wide perspective with real-life case studiesKlaus Wuchner, Felix Nikels, Patrick Garidel, et al.
Advanced Drug Delivery Reviews|April 3, 2024
Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product designNeil Mathias, Sylvain Huille, Marie Picci, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2021
Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranesAndra B Schromm, Laura Paulowski, Yani Kaconis, et al.
Journal of Pharmaceutical Sciences|February 22, 2022
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of PolysorbatesKlaus Wuchner, Linda Yi, Cyrille Chery, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Biophysical Journal|April 27, 2019
Structure of a Therapeutic Full-Length Anti-NPRA IgG4 Antibody: Dissecting Conformational DiversityMichaela Blech, Stefan Hörer, Alexander B Kuhn, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspectsTobias Schuerholz, Sabine Dömming, Mathias Hornef, et al.
Innate Immunity|April 5, 2008
Structural investigations into the interaction of hemoglobin and part structures with bacterial endotoxinsJörg Howe, Patrick Garidel, Manfred Roessle, et al.
The Journal of Biological Chemistry|February 9, 2008
Single particle characterization of iron-induced pore-forming alpha-synuclein oligomersMarcus Kostka, Tobias Högen, Karin M Danzer, et al.
Current Drug Targets|June 6, 2012
Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyaminesGuillermo Martínez de Tejada, Susana Sánchez-Gómez, Iosu Rázquin-Olazaran, et al.
Journal of Molecular Biology|March 22, 2017
Prediction and Reduction of the Aggregation of Monoclonal AntibodiesRob van der Kant, Anne R Karow-Zwick, Joost Van Durme, et al.
Journal of Pharmaceutical Sciences|January 19, 2026
Do we worry too much about polysorbate degradation? An industry-wide perspective with real-life case studiesKlaus Wuchner, Felix Nikels, Patrick Garidel, et al.
Advanced Drug Delivery Reviews|April 3, 2024
Towards more tolerable subcutaneous administration: Review of contributing factors for improving combination product designNeil Mathias, Sylvain Huille, Marie Picci, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2021
Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranesAndra B Schromm, Laura Paulowski, Yani Kaconis, et al.
Journal of Pharmaceutical Sciences|February 22, 2022
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of PolysorbatesKlaus Wuchner, Linda Yi, Cyrille Chery, et al.
Pageof 15